Clinical Trial Update: TAVNEOS for Otolaryngologic Manifestations of Granulomatosis With Polyangiitis [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update indicates a Phase 2/3 study of avacopan (TAVNEOS) for otolaryngologic manifestations of granulomatosis with polyangiitis is not yet recrui…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Granulomatosis with Polyangiitis

Drugs mentioned

• TAVNEOS (avacopan)

Snippet

Sponsor: Robert Spiera, MD | Conditions: Granulomatosis With Polyangiitis, Wegener's | Phase 2, Phase 3 | Status: NOT_YET_RECRUITING